(RBC) RBC Bearings - Ratings and Ratios
Bearings, Gears, Valves, Fasteners, Transmission Components
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 24.9% |
| Value at Risk 5%th | 36.5% |
| Relative Tail Risk | -10.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.96 |
| Alpha | 17.20 |
| CAGR/Max DD | 1.22 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.321 |
| Beta | 0.860 |
| Beta Downside | 0.786 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.53% |
| Mean DD | 6.45% |
| Median DD | 6.05% |
Description: RBC RBC Bearings October 31, 2025
RBC Bearings (NYSE:RBC) designs and manufactures precision bearings, components, and power-transmission systems for aerospace/defense and industrial markets. Its product portfolio spans self-lubricating plain bearings, tapered and needle roller bearings, high-precision ball bearings, mounted bearing assemblies, enclosed gearsets, couplings, hydraulic valves, fasteners, and machine-tool collets, serving customers from commercial and military aircraft to mining, energy, semiconductor equipment, and logistics.
Key financial snapshots (FY 2023) show revenue of roughly $1.2 billion, an operating margin of about 11 %, and a backlog of ~ $300 million, indicating a solid order pipeline but also exposure to cyclical industrial demand. The aerospace segment benefits from rising defense budgets-U.S. defense spending is projected to grow at ~3 % CAGR through 2028-while the industrial side tracks broader capital-expenditure trends, such as the 5-7 % annual growth in automation and material-handling equipment worldwide.
RBC’s competitive edge lies in its high-precision, low-friction bearing technology, which is critical for weight-critical aerospace platforms and for extending equipment life in harsh industrial environments. However, the company remains vulnerable to supply-chain constraints on specialty steels and to fluctuations in defense procurement cycles; a sustained slowdown in aerospace orders would materially compress margins.
For a deeper quantitative assessment of RBC’s valuation relative to peers, you may find the ValueRay platform’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (259.1m TTM) > 0 and > 6% of Revenue (6% = 103.4m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 0.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 47.48% (prev 45.75%; Δ 1.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 361.6m > Net Income 259.1m (YES >=105%, WARN >=100%) |
| Net Debt (1.04b) to EBITDA (505.3m) ratio: 2.07 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.18 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (31.6m) change vs 12m ago 7.67% (target <= -2.0% for YES) |
| Gross Margin 44.34% (prev 43.60%; Δ 0.73pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 35.09% (prev 33.78%; Δ 1.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.34 (EBITDA TTM 505.3m / Interest Expense TTM 52.6m) >= 6 (WARN >= 3) |
Altman Z'' 3.45
| (A) 0.16 = (Total Current Assets 1.19b - Total Current Liabilities 375.1m) / Total Assets 5.11b |
| (B) 0.31 = Retained Earnings (Balance) 1.58b / Total Assets 5.11b |
| (C) 0.08 = EBIT TTM 386.3m / Avg Total Assets 4.91b |
| (D) 0.82 = Book Value of Equity 1.58b / Total Liabilities 1.92b |
| Total Rating: 3.45 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 68.02
| 1. Piotroski 6.50pt |
| 2. FCF Yield 2.08% |
| 3. FCF Margin 17.67% |
| 4. Debt/Equity 0.36 |
| 5. Debt/Ebitda 2.07 |
| 6. ROIC - WACC (= -1.67)% |
| 7. RoE 8.44% |
| 8. Rev. Trend 83.34% |
| 9. EPS Trend 77.71% |
What is the price of RBC shares?
Over the past week, the price has changed by +3.48%, over one month by +3.84%, over three months by +14.77% and over the past year by +32.74%.
Is RBC a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the RBC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 479.8 | 7.8% |
| Analysts Target Price | 479.8 | 7.8% |
| ValueRay Target Price | 552 | 24% |
RBC Fundamental Data Overview November 26, 2025
P/E Trailing = 52.3114
P/E Forward = 14.5349
P/S = 7.8873
P/B = 4.2268
P/EG = 1.4525
Beta = 1.534
Revenue TTM = 1.72b USD
EBIT TTM = 386.3m USD
EBITDA TTM = 505.3m USD
Long Term Debt = 1.07b USD (from longTermDebt, last quarter)
Short Term Debt = 17.1m USD (from shortTermDebt, last quarter)
Debt = 1.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.04b USD (from netDebt column, last quarter)
Enterprise Value = 14.64b USD (13.59b + Debt 1.14b - CCE 91.2m)
Interest Coverage Ratio = 7.34 (Ebit TTM 386.3m / Interest Expense TTM 52.6m)
FCF Yield = 2.08% (FCF TTM 304.6m / Enterprise Value 14.64b)
FCF Margin = 17.67% (FCF TTM 304.6m / Revenue TTM 1.72b)
Net Margin = 15.03% (Net Income TTM 259.1m / Revenue TTM 1.72b)
Gross Margin = 44.34% ((Revenue TTM 1.72b - Cost of Revenue TTM 959.3m) / Revenue TTM)
Gross Margin QoQ = 44.06% (prev 44.77%)
Tobins Q-Ratio = 2.86 (Enterprise Value 14.64b / Total Assets 5.11b)
Interest Expense / Debt = 1.18% (Interest Expense 13.4m / Debt 1.14b)
Taxrate = 28.06% (23.4m / 83.4m)
NOPAT = 277.9m (EBIT 386.3m * (1 - 28.06%))
Current Ratio = 3.18 (Total Current Assets 1.19b / Total Current Liabilities 375.1m)
Debt / Equity = 0.36 (Debt 1.14b / totalStockholderEquity, last quarter 3.19b)
Debt / EBITDA = 2.07 (Net Debt 1.04b / EBITDA 505.3m)
Debt / FCF = 3.43 (Net Debt 1.04b / FCF TTM 304.6m)
Total Stockholder Equity = 3.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.07% (Net Income 259.1m / Total Assets 5.11b)
RoE = 8.44% (Net Income TTM 259.1m / Total Stockholder Equity 3.07b)
RoCE = 9.34% (EBIT 386.3m / Capital Employed (Equity 3.07b + L.T.Debt 1.07b))
RoIC = 6.87% (NOPAT 277.9m / Invested Capital 4.05b)
WACC = 8.54% (E(13.59b)/V(14.73b) * Re(9.18%) + D(1.14b)/V(14.73b) * Rd(1.18%) * (1-Tc(0.28)))
Discount Rate = 9.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.00%
[DCF Debug] Terminal Value 77.15% ; FCFE base≈285.2m ; Y1≈337.0m ; Y5≈520.3m
Fair Price DCF = 229.2 (DCF Value 7.25b / Shares Outstanding 31.6m; 5y FCF grow 19.33% → 3.0% )
EPS Correlation: 77.71 | EPS CAGR: 45.82% | SUE: 1.41 | # QB: 4
Revenue Correlation: 83.34 | Revenue CAGR: 15.30% | SUE: 1.10 | # QB: 2
EPS next Quarter (2025-12-31): EPS=2.84 | Chg30d=+0.080 | Revisions Net=+4 | Analysts=7
EPS current Year (2026-03-31): EPS=11.84 | Chg30d=+0.317 | Revisions Net=+5 | Growth EPS=+18.3% | Growth Revenue=+13.4%
EPS next Year (2027-03-31): EPS=13.34 | Chg30d=+0.176 | Revisions Net=+4 | Growth EPS=+12.7% | Growth Revenue=+10.9%
Additional Sources for RBC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle